CVS Health Corporation $CVS Shares Bought by State Street Corp

State Street Corp lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 26.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,927,064 shares of the pharmacy operator’s stock after purchasing an additional 15,604,883 shares during the period. State Street Corp owned about 0.06% of CVS Health worth $7,751,205,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Security National Bank of SO Dak acquired a new stake in shares of CVS Health during the 2nd quarter worth about $32,000. Wellington Altus USA Inc. boosted its position in CVS Health by 13.3% during the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after acquiring an additional 120 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in CVS Health by 5.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,287,441 shares of the pharmacy operator’s stock valued at $133,186,000 after acquiring an additional 70,197 shares during the last quarter. Tortoise Investment Management LLC purchased a new position in shares of CVS Health during the 2nd quarter worth $254,000. Finally, Sequoia Financial Advisors LLC boosted its holdings in shares of CVS Health by 3.0% during the second quarter. Sequoia Financial Advisors LLC now owns 55,759 shares of the pharmacy operator’s stock worth $5,768,000 after purchasing an additional 1,646 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 0.1%

CVS traded up $0.13 on Tuesday, reaching $87.73. 2,853,360 shares of the company’s stock were exchanged, compared to its average volume of 8,212,691. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company’s 50 day moving average is $98.42 and its 200-day moving average is $91.42. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market cap of $112.21 billion, a price-to-earnings ratio of 23.19, a PEG ratio of 0.87 and a beta of 0.59.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the firm earned $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.0%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CVS shares. Royal Bank Of Canada upped their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. UBS Group restated a “buy” rating on shares of CVS Health in a report on Tuesday. Sanford C. Bernstein reiterated an “outperform” rating and set a $112.00 price objective on shares of CVS Health in a report on Wednesday, September 9th. Barclays raised their target price on shares of CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Argus upped their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. Twenty-two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $107.24.

About CVS Health

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.